Michael J. Satlin

12.5k total citations · 1 hit paper
116 papers, 4.0k citations indexed

About

Michael J. Satlin is a scholar working on Molecular Medicine, Epidemiology and Pharmacology. According to data from OpenAlex, Michael J. Satlin has authored 116 papers receiving a total of 4.0k indexed citations (citations by other indexed papers that have themselves been cited), including 63 papers in Molecular Medicine, 44 papers in Epidemiology and 37 papers in Pharmacology. Recurrent topics in Michael J. Satlin's work include Antibiotic Resistance in Bacteria (63 papers), Antibiotics Pharmacokinetics and Efficacy (37 papers) and Antibiotic Use and Resistance (19 papers). Michael J. Satlin is often cited by papers focused on Antibiotic Resistance in Bacteria (63 papers), Antibiotics Pharmacokinetics and Efficacy (37 papers) and Antibiotic Use and Resistance (19 papers). Michael J. Satlin collaborates with scholars based in United States, Australia and Japan. Michael J. Satlin's co-authors include Thomas J. Walsh, Stephen G. Jenkins, Lars F. Westblade, Matthew S. Simon, Rosemary Soave, Barry N. Kreiswirth, Amy J. Mathers, Julie Ann Justo, Emily L. Heil and Pranita D. Tamma and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Michael J. Satlin

110 papers receiving 3.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Infectious Diseases Society of America 2024 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections

2024 328 citations Pranita D. Tamma, Emily L. Heil et al. Clinical Infectious Diseases profile →

Peers

Countries citing papers authored by Michael J. Satlin

Since Specialization

Citations

This map shows the geographic impact of Michael J. Satlin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael J. Satlin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael J. Satlin more than expected).

Fields of papers citing papers by Michael J. Satlin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Michael J. Satlin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael J. Satlin. The network helps show where Michael J. Satlin may publish in the future.

Co-authorship network of co-authors of Michael J. Satlin

This figure shows the co-authorship network connecting the top 25 collaborators of Michael J. Satlin. A scholar is included among the top collaborators of Michael J. Satlin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Michael J. Satlin. Michael J. Satlin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Rapid detection of gram-negative antimicrobial resistance determinants directly from positive blood culture broths using a multiplex PCR system 2025 ·Journal of Clinical Microbiology ·(unknown), (unknown), (unknown), (unknown), (unknown), Kathy Fauntleroy, Amy Robertson, Barry N. Kreiswirth, Liang Chen, (unknown), (unknown), Andrew Hemmert, Aileen M. Davis, Michael J. Satlin, Lars F. Westblade	0
2	101. Patients with Carbapenem-resistant Klebsiella aerogenes and Enterobacter cloacae complex Colonization or Infection Have Different Baseline Characteristics but Similar Mortality and Clinical Outcomes 2025 ·Open Forum Infectious Diseases ·(unknown), (unknown), Lauren Komarow, Jesse T. Jacob, Michael J. Satlin, Keith S. Kaye, Blake Hanson, Gregory Weston, (unknown), Eric Cober, Sorabh Dhar, Jianping Jiang, Chen Liang, Carol Hill, Angelique E Boutzoukas, Tessa M. Andermann, David van Duin	0
3	Turning the Tide Against Carbapenem-resistant Acinetobacter baumannii : Advancing Care With Sulbactam–Durlobactam 2025 ·Open Forum Infectious Diseases ·Michael J. Satlin, Ryan K. Shields, Antoní Torres, Glenn Tillotson	0
4	Tackling antimicrobial resistance in people who are immunocompromised: leveraging diagnostic and antimicrobial stewardship 2025 ·The Lancet Infectious Diseases ·Catherine Liu, Emily A. Rosen, (unknown), Hannah Imlay, Masayuki Nigo, (unknown), Miranda So, Frank Tverdek, Sanjeet Dadwal, Carlota Gudiol, Michael J. Satlin, Susan K. Seo, Jason A. Trubiano, Ritu Banerjee, Kimberly E. Hanson, Lilian M. Abbo	1
5	Increased mortality in hospital- compared to community-onset carbapenem-resistant enterobacterales infections 2024 ·Journal of Antimicrobial Chemotherapy ·Angelique E Boutzoukas, Natalie A Mackow, (unknown), Lauren Komarow, Carol Hill, Liang Chen, Yohei Doi, Michael J. Satlin, César A. Arias, Minggui Wang, (unknown), Erica Herc, Eric Cober, Gregory Weston, Robin Patel, Robert A. Bonomo, Vance G. Fowler, David van Duin	2
6	Carbapenem-resistant Enterobacterales in solid organ transplant recipients 2024 ·American Journal of Transplantation ·Angelique E Boutzoukas, (unknown), Eric Cober, Lilian M. Abbo, Lauren Komarow, Liang Chen, Carol Hill, Michael J. Satlin, Matthew Grant, Bettina C. Fries, Gopi Patel, Todd P McCarty, César A. Arias, Robert A. Bonomo, David van Duin, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	0
7	Infectious Diseases Society of America 2024 Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections breakdown → 2024 ·Clinical Infectious Diseases ·Pranita D. Tamma, Emily L. Heil, Julie Ann Justo, Amy J. Mathers, Michael J. Satlin, Robert A Bonomo	328
8	14-Year Epidemiologic study of Pseudomonas aeruginosa bloodstream infection incidence and resistance in the Veterans Health Administration system, 2009–2022 2024 ·JAC-Antimicrobial Resistance ·(unknown), Brigid Wilson, Michael J. Satlin, Federico Pérez, María F. Mojica, Mendel E. Singer, Robert A. Bonomo, Lauren Epstein	3
9	Cefiderocol Treatment for Patients with Multidrug- and Carbapenem-Resistant Pseudomonas aeruginosa Infections in the Compassionate Use Program 2023 ·Antimicrobial Agents and Chemotherapy ·Michael J. Satlin, Patricia J. Simner, (unknown), Yoshinori Yamano, Tsutae Den Nagata, Simon Portsmouth	24
10	Global impact of antibacterial resistance in patients with hematologic malignancies and hematopoietic cell transplant recipients 2023 ·Transplant Infectious Disease ·(unknown), Michael J. Satlin	6
11	Efficacy of Cefiderocol in Experimental Stenotrophomonas maltophilia Pneumonia in Persistently Neutropenic Rabbits 2022 ·Antimicrobial Agents and Chemotherapy ·Vidmantas Petraitis, Rūta Petraitienė, Povilas Kavaliauskas, (unknown), Andrew Garcia, (unknown), Roger Echols, Robert A. Bonomo, Yoshinori Yamano, Michael J. Satlin, Thomas J. Walsh	14
12	Carbapenem-Resistant Acinetobacter baumannii in U.S. Hospitals: Diversification of Circulating Lineages and Antimicrobial Resistance 2022 ·mBio ·Alina Iovleva, Mustapha M. Mustapha, M. Patrick Griffith, Lauren Komarow, Courtney Luterbach, Daniel R. Evans, Eric Cober, Sandra S. Richter, (unknown), César A. Arias, Jesse T. Jacob, Robert A. Salata, Michael J. Satlin, Darren Wong, Robert A. Bonomo, David van Duin, Vaughn S. Cooper, Daria Van Tyne, Yohei Doi	60
13	Impact of pre‐transplant carbapenem‐resistant Enterobacterales colonization and/or infection on solid organ transplant outcomes 2021 ·Clinical Transplantation ·Sarah Taimur, Stephanie M. Pouch, Nicole Zubizarreta, Madhu Mazumdar, Meenakshi Rana, Gopi Patel, (unknown), Rebecca Pellett Madan, E.J. Kwak, Emily A. Blumberg, Michael J. Satlin, (unknown), Wanessa Trindade Clemente, Marcus Zervos, Ricardo M. La Hoz, Shirish Huprikar	23
14	Real-world implementation and impact of a rapid carbapenemase detection test in an area endemic for carbapenem-resistant Enterobacterales 2021 ·Infection Control and Hospital Epidemiology ·Alex Trzebucki, Lars F. Westblade, Angela Loo, (unknown), Stephen G. Jenkins, David P. Calfee, Michael J. Satlin, Matthew S. Simon	2
15	Machine Learning Highlights Downtrending of COVID-19 Patients with a Distinct Laboratory Profile 2021 ·SHILAP Revista de lepidopterología ·He S. Yang, Yu Hou, Hao Zhang, Amy Chadburn, Lars F. Westblade, (unknown), Peter A.D. Steel, Sabrina Racine‐Brzostek, Priya Velu, Jorge L. Sepulveda, Michael J. Satlin, Melissa M. Cushing, Rainu Kaushal, Zhen Zhao, Fei Wang	3
16	Adenovirus viremia after in vivo T-cell depleted allo-transplant in adults: low lymphocyte counts are associated with uncontrolled viremia and fatal outcomes 2021 ·Leukemia & lymphoma ·(unknown), Rosemary Soave, Zhengming Chen, Tsiporah B. Shore, Sebastian Mayer, Adrienne A. Phillips, (unknown), (unknown), Hanna Rennert, (unknown), (unknown), Thomas J. Walsh, Catherine B. Small, Rosy Priya Kodiyanplakkal, Markus Plate, Michael J. Satlin, Koen van Besien	2
17	The ERACE-PA Global Surveillance Program: Ceftolozane/tazobactam and Ceftazidime/avibactam in vitro Activity against a Global Collection of Carbapenem-resistant Pseudomonas aeruginosa 2021 ·European Journal of Clinical Microbiology & Infectious Diseases ·Christian M Gill, (unknown), Wadha Alfouzan, Lori Bourassa, Adrian Brink, Carey‐Ann D. Burnham, Rafael Cantón, Yehuda Carmeli, Marco Falcone, Carlos Roberto Veiga Kiffer, Anna Marchese, Octavio Martínez, Spyros Pournaras, Michael J. Satlin, Harald Seifert, Abrar K. Thabit, Kenneth S. Thomson, María Virginia Villegas, David P. Nicolau, (unknown)	70
18	Safety, tolerability, and clinical outcomes of hydroxychloroquine for hospitalized patients with coronavirus 2019 disease 2020 ·PLoS ONE ·Michael J. Satlin, Parag Goyal, Reed Magleby, (unknown), (unknown), Maiko Kondo, Edward J. Schenck, Hanna Rennert, Lars F. Westblade, Justin J. Choi, Monika M. Safford, Roy M. Gulick	19
19	Bacteremia due to carbapenem-resistant Enterobacteriaceae in neutropenic patients with hematologic malignancies 2016 ·Journal of Infection ·Michael J. Satlin, Nina Cohen, C. Kevin, (unknown), Rosemary Soave, Gülce Askin, Liang Chen, Barry N. Kreiswirth, Thomas J. Walsh, Susan K. Seo	107
20	Glycemic Control in HIV-Infected Patients with Diabetes Mellitus and Rates of Meeting American Diabetes Association Management Guidelines 2011 ·AIDS Patient Care and STDs ·Michael J. Satlin, Donald R. Hoover, Marshall J. Glesby	22

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact